San Diego Airport ⇄ Clinic transportation available • English & Spanish support • Free eligibility call

Learn more...

1. Back and Joint Pain.

Osteoarthritis Stem cell–based orthopedic injections are being studied for their ability to calm inflammation and support the joint environment—especially in osteoarthritis, where cartilage wear and chronic inflammation drive pain and stiffness. Most protocols use mesenchymal stromal/stem cells (MSCs) sourced from tissues such as bone marrow or adipose tissue. Rather than “building a brand-new joint,” MSCs may help by releasing signals that reduce inflammatory activity and support tissue repair processes over time. What patients may notice: Many people seek these therapies to improve daily function—walking, stairs, standing longer—and to reduce reliance on pain medications. Because injection treatments can also have a meaningful placebo response, results vary and improvement is not guaranteed. Best-fit candidates are typically those with persistent symptoms despite conservative care (physical therapy, weight management, anti-inflammatory strategies) who want to explore options before major surgery. Realistic expectations: the most common goal is symptom relief and better function, not a “cure.” Your care plan should include rehab and lifestyle support to get the best chance of improvement.

2. Sports Injuries.

Sports injuries often involve more than a torn structure—they involve inflammation, tissue irritation, and slow healing in tendons, ligaments, or cartilage. Stem cell–based approaches (often MSCs) are being explored as a way to optimize the healing environment by reducing inflammatory signaling and supporting repair pathways that are active during recovery. Where this may help: chronic tendon pain, stubborn soft-tissue injuries, or joint irritation that hasn’t responded to rest, rehab, and standard treatments. The goal is to support the body’s repair process so patients can return to training with less pain and better movement quality. What to expect: improvement is typically gradual—measured in weeks to months—especially when paired with a structured rehabilitation plan. It’s important to understand that the clinical evidence base is still evolving in many sports-medicine indications, and outcomes depend heavily on the specific diagnosis and severity.

worm's-eye view photography of concrete building

3. Stroke.

After a stroke, the brain can be left with a combination of tissue injury, inflammation, and disrupted signaling pathways that affect movement, speech, and cognition. Researchers are studying stem cell–based therapies for stroke because certain cell types may help regulate inflammation and support the brain’s natural recovery processes. What this therapy is (and is not): It’s not a “brain transplant,” and it does not reverse time. The intent is to support recovery potential—often alongside rehabilitation—by creating a biological environment that may be more favorable for repair and functional improvement. Meta-analyses of clinical studies continue to evaluate safety and signals of benefit, but responses vary and research is ongoing. Best results usually come from combining approaches: rehab therapy, risk-factor control, and a realistic step-by-step recovery plan.

4. Neurology Disease.

Neurological diseases are complex because they involve long-term changes in nerve cells, inflammation, and impaired signaling. Stem cell research in neurology spans multiple directions: Cell-replacement strategies (for example, in Parkinson’s disease) aim to restore specific types of neurons and are being tested in early-stage clinical studies. Immunomodulatory strategies (often using MSCs) are being studied in conditions where inflammation plays a major role, such as multiple sclerosis, with mixed but actively developing evidence. What patients should know: neurology is one of the most active research areas in regenerative medicine, but it’s also one where honest expectations matter most. The primary goals are often quality of life, function, and symptom support—and any plan should be guided by careful medical evaluation, diagnosis specificity, and safety screening.

5. Spinal Cord Injury.

Spinal cord injury can disrupt nerve pathways that control movement, sensation, and autonomic function. Stem cell–based therapies are being studied because certain cells may help modulate inflammation, support nerve-protective signals, and potentially enhance the recovery environment in the injured spinal cord. Where research is today: clinical studies and reviews continue to investigate the safest ways to deliver cells and which patients may benefit most. Some analyses report signals of neurological improvement in subsets of patients, but outcomes vary widely depending on injury level, timing, and severity—and research is still evolving. What this can mean for patients: the focus is often on incremental gains—improving strength, reducing spasticity or neuropathic symptoms, and supporting functional independence—paired with rehabilitation and long-term supportive care.

6. Autoimmune and Chronic Conditions.

Many autoimmune and chronic conditions are driven by immune dysregulation—where the immune system stays “stuck” in an inflammatory mode. Because mesenchymal stromal/stem cells (MSCs) can influence immune signaling, they’re being studied for their potential to modulate immune activity and reduce inflammatory burden in selected conditions. Important nuance: autoimmune disease is not one category. Evidence and outcomes differ dramatically by diagnosis (and by organ involvement). In some fields, stem cell approaches are established (for example, hematopoietic stem cell transplantation in specific blood/immune disorders), while in others they remain investigational with ongoing clinical studies. For certain Crohn’s complications (like complex perianal fistulas), specialized cell products have been used internationally, but regulatory status has changed over time—highlighting how carefully these therapies must be evaluated. Best-practice positioning: focus on realistic goals—symptom control, flare reduction, and improved daily function—while emphasizing individualized evaluation and safety-first care.